CLOs on the Move

Karl Storz - Endoskope

www.ksea.com

 
Karl Storz - Endoskope is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ksea.com
  • 2151 E Grand Ave Ste 100
    El Segundo, CA USA 90245
  • Phone: 424.218.8100

Executives

Name Title Contact Details

Similar Companies

Charm Health

Charm Health is a Bardon Qld, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

XACT Robotics

XACT Robotics® is a privately held company focused on advancing the field of radiology by developing the world`s first and only hands-free robotic solutions that can significantly improve targeting accuracy, efficiency, and consistency in percutaneous radiology procedures. The company was founded in 2013 by Harel Gadot, a renowned entrepreneur in the MedTech robotics space, whose vision reimagined how image-guided percutaneous procedures are performed. At XACT, we embrace the philosophy of collaboration, tenacity, and extreme ownership. Our family culture empowers and inspires as we partner, develop, and execute meaningful technologies to make a difference in the lives of patients. Our company`s leadership is comprised of start-up, robotic, and disruptive technology experts with deep knowledge, vast experience and the diverse leadership skills required in the robotic market.

Meridian Medical Group

Meridian Medical Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cierra

Cierra is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Invendo Medical

Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on